Marta Kaķe

Ms. Marta Kaķe

Riga Stradiņš University, Riga, Rīga, Latvia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2026 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
MKMarta Kaķe
Marta Kaķe
VBVanda Bondare-Ansberga
Vanda Bondare-Ansberga
IMIngmārs Mikažāns
Ingmārs Mikažāns
MŠMihails Ščerbuks
Mihails Ščerbuks
EZEvija Zītare
Evija Zītare

1 January 2026 in Dermatologic Therapy
Verified
Journal Article
Open access
PDF file
MKMarta Kaķe
Marta Kaķe
IUIlze Upeniece
Ilze Upeniece
Introduction: Atopic dermatitis (AD) significantly burdens the quality of life of patients and their families. This study assesses the proportion of patients with AD who followed the European Academy of Dermatology and Venereology (EADV) guidelines for emollient use and examines its correlation with disease severity assessed using the Patient‐Oriented Eczema Measure (POEM). Methods: A questionnaire‐based survey was conducted among patients of Riga First Hospital with AD diagnosis. The questionnaire included the POEM score and items assessing emollient‐use behaviors. The analysis was performed using IBM SPSS version 29. Results: Among 92 patients with AD, reported adherence to emollient‐use guidelines was low: 37% applied emollients ≥ 2 times/day, 31.5% applied whole body, 28.3% used them daily regardless of symptoms, and only 23.9% used adequate volumes (≥ 200 mL/week). Patients with severe AD were more likely to apply emollients ≥ 2 times/day ( p = 0.004) and daily, regardless of symptoms ( p = 0.005). A greater proportion of adults reported applying emollients ≥ 2 times/day (48.1% vs. 15.5%, p = 0.001). Overall, 42% reported adverse reactions, most commonly burning or irritation. Conclusions: Emollient use remains suboptimal. These findings highlight the need for improved adherence support, better product tolerability, and consideration of economic factors in AD management.